Drug-coated Balloons Market Current Scenario with Future Aspect Analysis

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Drug-coated Balloons Market- by Product (Drug-Coated Balloons for Peripheral Artery Disease, Drug-Coated Balloons for Coronary Artery Disease and Drug-Coated Balloons for Other Indications), End User (Hospitals, Cardiac Catherization Labs and Ambulatory Surgical Centers), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."

According to the latest research by InsightAce Analytic, the Drug-coated Balloons Market Size is valued at 594.0 Million in 2022 and is predicted to reach 1301.8 Million by the year 2031 at a 9.2 % CAGR during the forecast period for 2023-2031.

Request For Free Sample Pages:
https://www.insightaceanalytic.com/request-sample/1099

Drug-coated balloons (DCBs) are semi-compliant angioplasty balloons that are coated with cytotoxic chemotherapeutic agents. Among commercially available options, paclitaxel-coated balloons are gaining increasing traction. DCBs have emerged as a novel alternative to drug-eluting stents, offering potential benefits in treating complex patient populations. Recent preclinical and clinical research has explored their application in both coronary and peripheral vascular procedures, producing encouraging outcomes that underscore their growing role in interventional cardiology and vascular therapy.

The global market for drug-coated balloons is projected to grow steadily, supported by advancements in medical technology and a rising preference for minimally invasive procedures. The increasing incidence of coronary and peripheral artery diseases worldwide significantly contributes to market demand. Additionally, the expanding elderly population in developing regions, combined with a growing number of patients affected by cardiovascular conditions, further fuels market growth.

Curious about this latest version of the report? Obtain Report Details @ https://www.insightaceanalytic.com/enquiry-before-buying/1099

North America is anticipated to contribute to the Drug-coated Balloons market. A sizable disease population's prevalence and improved treatment access are the fundamental causes of the high market share. The North American market is predicted to grow profitably during the projection period due to new product approvals, expanded indication approvals for commercially existing DCBs, the availability of a plethora of clinical evidence, and the approval of new products. In addition, the Asia Pacific Drug-coated Balloons market is expected to register significant growth due to the aging population in the area, the desire for higher-quality healthcare, and the rise in the prevalence of cardiovascular diseases. China's aging population is contributing to an increase in cardiovascular ailments and disorders.

Major market players operating in the Drug-coated Balloons market include
Medtronic, BD, Koninklijke Philips, B. Braun Melsungen, BIOTRONIK, Boston Scientific, Opto Circuits (India), Acotec Scientific, AR Baltic Medical, Acrostak, Biosensors International Group, Cardionovum, Concept Medical, ENDOCOR, Hexacath, iVascular SLU, M.A. Med Alliance, Minvasys, Orchestra BioMed, QT Vascular, RD Global-Invamed, Surmodics, Terumo, Welling, and Other prominent players.

Recent collaborations and agreements in the market:
• In May 2022, FDA approval for the investigational device exemption was given to MedAlliance's SELUTION SLR Drug-eluting Balloon. The novel sirolimus-eluting balloon known as the SELUTION SLR (Sustained Limus Release) gives a regulated and sustained drug release, much like a drug-eluting stent.
• In June 2020, iVascular SLU introduced Essential Pro, a ground-breaking coronary artery drug-coated balloon, on a global scale (DCB). The Essential Pro DCB improves on its predecessor in several ways, including more excellent safety and quick deflation times owing to an extension of the inflating channel and the availability of two different shaft options.

Get Specific Chapter/Information From The Report:
https://www.insightaceanalytic.com/customisation/1099

Market Segments
Global Drug-coated Balloons Market, by Product, 2023-2021 (Value US$ Mn)
• Drug-Coated Balloons for Peripheral Artery Disease
• Drug-Coated Balloons for Coronary Artery Disease
• Drug-Coated Balloons for Other Indications
Global Drug-coated Balloons Market, by End User, 2023-2031 (Value US$ Mn)
• Hospitals
• Cardiac Catheterization Labs
• Ambulatory Surgical Centers
Global Drug-coated Balloons Market, by Region, 2023-2031 (Value US$ Mn)
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa
North America Drug-coated Balloons Market, by Country, 2023-2031 (Value US$ Mn)
• U.S.
• Canada
Europe Drug-coated Balloons Market, by Country, 2023-2021 (Value US$ Mn)
• Germany
• France
• Italy
• Spain
• Russia
• Rest of Europe
Asia Pacific Drug-coated Balloons Market, by Country, 2023-2031 (Value US$ Mn)
• India
• China
• Japan
• South Korea
• Australia & New Zealand
Latin America Drug-coated Balloons Market, by Country, 2023-2031 (Value US$ Mn)
• Brazil
• Mexico
• Rest of Latin America
Middle East & Africa Drug-coated Balloons Market, by Country, 2023-2031 (Value US$ Mn)
• GCC Countries
• South Africa
• Rest of Middle East & Africa

Get More Information: @
https://www.insightaceanalytic.com/report/global-drug-coated-balloons-market-/1099

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.https://www.insightaceanalytic.com/images_data/148861653.

Contact Us:
info@insightaceanalytic.com
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 607 400-7072
Asia: +91 79 72967118
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ
Twitter: https://twitter.com/Insightace

This release was published on openPR.